How to use the speech recognition tool?
A Study to Determine the Safety and Efficacy of RenexusÂ® in Macular Telangiectasia Type 2.
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: NA
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators